Global Pneumonia Market 2022 by Company, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 282538
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Pneumonia market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Pneumonia market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals accounting for % of the Pneumonia global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Drugs segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Pneumonia include Pfizer, GlaxoSmithKline(GSK), Merck, Novartis, and Sanofi, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Pneumonia market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Drugs

Vaccines

Oxygen Therapy

Market segment by Application, can be divided into

Hospitals

Ambulatory Surgical Centers

Others

Market segment by players, this report covers

Pfizer

GlaxoSmithKline(GSK)

Merck

Novartis

Sanofi

Eli Lilly

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Pneumonia product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Pneumonia, with revenue, gross margin and global market share of Pneumonia from 2019 to 2022.

Chapter 3, the Pneumonia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Pneumonia market forecast, by regions, type and application, with revenue, from 2023 to 2028.

Chapter 11 and 12, to describe Pneumonia research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Product Overview and Scope of Pneumonia

1.2 Classification of Pneumonia by Type

1.2.1 Overview: Global Pneumonia Market Size by Type: 2017 Versus 2021 Versus 2028

1.2.2 Global Pneumonia Revenue Market Share by Type in 2021

1.2.3 Drugs

1.2.4 Vaccines

1.2.5 Oxygen Therapy

1.3 Global Pneumonia Market by Application

1.3.1 Overview: Global Pneumonia Market Size by Application: 2017 Versus 2021 Versus 2028

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Global Pneumonia Market Size & Forecast

1.5 Global Pneumonia Market Size and Forecast by Region

1.5.1 Global Pneumonia Market Size by Region: 2017 VS 2021 VS 2028

1.5.2 Global Pneumonia Market Size by Region, (2017-2022)

1.5.3 North America Pneumonia Market Size and Prospect (2017-2028)

1.5.4 Europe Pneumonia Market Size and Prospect (2017-2028)

1.5.5 Asia-Pacific Pneumonia Market Size and Prospect (2017-2028)

1.5.6 South America Pneumonia Market Size and Prospect (2017-2028)

1.5.7 Middle East and Africa Pneumonia Market Size and Prospect (2017-2028)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pneumonia Market Drivers

1.6.2 Pneumonia Market Restraints

1.6.3 Pneumonia Trends Analysis

2 Company Profiles

2 Company Profiles

2.1 Pfizer

2.1.1 Pfizer Details

2.1.2 Pfizer Major Business

2.1.3 Pfizer Pneumonia Product and Solutions

2.1.4 Pfizer Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.1.5 Pfizer Recent Developments and Future Plans

2.2 GlaxoSmithKline(GSK)

2.2.1 GlaxoSmithKline(GSK) Details

2.2.2 GlaxoSmithKline(GSK) Major Business

2.2.3 GlaxoSmithKline(GSK) Pneumonia Product and Solutions

2.2.4 GlaxoSmithKline(GSK) Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2.5 GlaxoSmithKline(GSK) Recent Developments and Future Plans

2.3 Merck

2.3.1 Merck Details

2.3.2 Merck Major Business

2.3.3 Merck Pneumonia Product and Solutions

2.3.4 Merck Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3.5 Merck Recent Developments and Future Plans

2.4 Novartis

2.4.1 Novartis Details

2.4.2 Novartis Major Business

2.4.3 Novartis Pneumonia Product and Solutions

2.4.4 Novartis Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4.5 Novartis Recent Developments and Future Plans

2.5 Sanofi

2.5.1 Sanofi Details

2.5.2 Sanofi Major Business

2.5.3 Sanofi Pneumonia Product and Solutions

2.5.4 Sanofi Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5.5 Sanofi Recent Developments and Future Plans

2.6 Eli Lilly

2.6.1 Eli Lilly Details

2.6.2 Eli Lilly Major Business

2.6.3 Eli Lilly Pneumonia Product and Solutions

2.6.4 Eli Lilly Pneumonia Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6.5 Eli Lilly Recent Developments and Future Plans

3 Market Competition, by Players

3 Market Competition, by Players

3.1 Global Pneumonia Revenue and Share by Players (2019, 2020, 2021, and 2022)

3.2 Market Concentration Rate

3.2.1 Top 3 Pneumonia Players Market Share in 2021

3.2.2 Top 10 Pneumonia Players Market Share in 2021

3.2.3 Market Competition Trend

3.3 Pneumonia Players Head Office, Products and Services Provided

3.4 Pneumonia Mergers & Acquisitions

3.5 Pneumonia New Entrants and Expansion Plans

4 Market Size Segment by Type

4 Market Size Segment by Type

4.1 Global Pneumonia Revenue and Market Share by Type (2017-2022)

4.2 Global Pneumonia Market Forecast by Type (2023-2028)

5 Market Size Segment by Application

5 Market Size Segment by Application

5.1 Global Pneumonia Revenue Market Share by Application (2017-2022)

5.2 Global Pneumonia Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application

6 North America by Country, by Type, and by Application

6.1 North America Pneumonia Revenue by Type (2017-2028)

6.2 North America Pneumonia Revenue by Application (2017-2028)

6.3 North America Pneumonia Market Size by Country

6.3.1 North America Pneumonia Revenue by Country (2017-2028)

6.3.2 United States Pneumonia Market Size and Forecast (2017-2028)

6.3.3 Canada Pneumonia Market Size and Forecast (2017-2028)

6.3.4 Mexico Pneumonia Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application

7 Europe by Country, by Type, and by Application

7.1 Europe Pneumonia Revenue by Type (2017-2028)

7.2 Europe Pneumonia Revenue by Application (2017-2028)

7.3 Europe Pneumonia Market Size by Country

7.3.1 Europe Pneumonia Revenue by Country (2017-2028)

7.3.2 Germany Pneumonia Market Size and Forecast (2017-2028)

7.3.3 France Pneumonia Market Size and Forecast (2017-2028)

7.3.4 United Kingdom Pneumonia Market Size and Forecast (2017-2028)

7.3.5 Russia Pneumonia Market Size and Forecast (2017-2028)

7.3.6 Italy Pneumonia Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pneumonia Revenue by Type (2017-2028)

8.2 Asia-Pacific Pneumonia Revenue by Application (2017-2028)

8.3 Asia-Pacific Pneumonia Market Size by Region

8.3.1 Asia-Pacific Pneumonia Revenue by Region (2017-2028)

8.3.2 China Pneumonia Market Size and Forecast (2017-2028)

8.3.3 Japan Pneumonia Market Size and Forecast (2017-2028)

8.3.4 South Korea Pneumonia Market Size and Forecast (2017-2028)

8.3.5 India Pneumonia Market Size and Forecast (2017-2028)

8.3.6 Southeast Asia Pneumonia Market Size and Forecast (2017-2028)

8.3.7 Australia Pneumonia Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application

9 South America by Country, by Type, and by Application

9.1 South America Pneumonia Revenue by Type (2017-2028)

9.2 South America Pneumonia Revenue by Application (2017-2028)

9.3 South America Pneumonia Market Size by Country

9.3.1 South America Pneumonia Revenue by Country (2017-2028)

9.3.2 Brazil Pneumonia Market Size and Forecast (2017-2028)

9.3.3 Argentina Pneumonia Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pneumonia Revenue by Type (2017-2028)

10.2 Middle East & Africa Pneumonia Revenue by Application (2017-2028)

10.3 Middle East & Africa Pneumonia Market Size by Country

10.3.1 Middle East & Africa Pneumonia Revenue by Country (2017-2028)

10.3.2 Turkey Pneumonia Market Size and Forecast (2017-2028)

10.3.3 Saudi Arabia Pneumonia Market Size and Forecast (2017-2028)

10.3.4 UAE Pneumonia Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

11 Research Findings and Conclusion

12 Appendix

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pneumonia Revenue by Type, (USD Million), 2017 VS 2021 VS 2028

Table 2. Global Pneumonia Revenue by Application, (USD Million), 2017 VS 2021 VS 2028

Table 3. Global Market Pneumonia Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)

Table 4. Global Pneumonia Revenue (USD Million) by Region (2017-2022)

Table 5. Global Pneumonia Revenue Market Share by Region (2023-2028)

Table 6. Pfizer Corporate Information, Head Office, and Major Competitors

Table 7. Pfizer Major Business

Table 8. Pfizer Pneumonia Product and Solutions

Table 9. Pfizer Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 10. GlaxoSmithKline(GSK) Corporate Information, Head Office, and Major Competitors

Table 11. GlaxoSmithKline(GSK) Major Business

Table 12. GlaxoSmithKline(GSK) Pneumonia Product and Solutions

Table 13. GlaxoSmithKline(GSK) Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 14. Merck Corporate Information, Head Office, and Major Competitors

Table 15. Merck Major Business

Table 16. Merck Pneumonia Product and Solutions

Table 17. Merck Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 18. Novartis Corporate Information, Head Office, and Major Competitors

Table 19. Novartis Major Business

Table 20. Novartis Pneumonia Product and Solutions

Table 21. Novartis Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 22. Sanofi Corporate Information, Head Office, and Major Competitors

Table 23. Sanofi Major Business

Table 24. Sanofi Pneumonia Product and Solutions

Table 25. Sanofi Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 26. Eli Lilly Corporate Information, Head Office, and Major Competitors

Table 27. Eli Lilly Major Business

Table 28. Eli Lilly Pneumonia Product and Solutions

Table 29. Eli Lilly Pneumonia Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 30. Global Pneumonia Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)

Table 31. Global Pneumonia Revenue Share by Players (2019, 2020, 2021, and 2022)

Table 32. Breakdown of Pneumonia by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Pneumonia Players Head Office, Products and Services Provided

Table 34. Pneumonia Mergers & Acquisitions in the Past Five Years

Table 35. Pneumonia New Entrants and Expansion Plans

Table 36. Global Pneumonia Revenue (USD Million) by Type (2017-2022)

Table 37. Global Pneumonia Revenue Share by Type (2017-2022)

Table 38. Global Pneumonia Revenue Forecast by Type (2023-2028)

Table 39. Global Pneumonia Revenue by Application (2017-2022)

Table 40. Global Pneumonia Revenue Forecast by Application (2023-2028)

Table 41. North America Pneumonia Revenue by Type (2017-2022) & (USD Million)

Table 42. North America Pneumonia Revenue by Type (2023-2028) & (USD Million)

Table 43. North America Pneumonia Revenue by Application (2017-2022) & (USD Million)

Table 44. North America Pneumonia Revenue by Application (2023-2028) & (USD Million)

Table 45. North America Pneumonia Revenue by Country (2017-2022) & (USD Million)

Table 46. North America Pneumonia Revenue by Country (2023-2028) & (USD Million)

Table 47. Europe Pneumonia Revenue by Type (2017-2022) & (USD Million)

Table 48. Europe Pneumonia Revenue by Type (2023-2028) & (USD Million)

Table 49. Europe Pneumonia Revenue by Application (2017-2022) & (USD Million)

Table 50. Europe Pneumonia Revenue by Application (2023-2028) & (USD Million)

Table 51. Europe Pneumonia Revenue by Country (2017-2022) & (USD Million)

Table 52. Europe Pneumonia Revenue by Country (2023-2028) & (USD Million)

Table 53. Asia-Pacific Pneumonia Revenue by Type (2017-2022) & (USD Million)

Table 54. Asia-Pacific Pneumonia Revenue by Type (2023-2028) & (USD Million)

Table 55. Asia-Pacific Pneumonia Revenue by Application (2017-2022) & (USD Million)

Table 56. Asia-Pacific Pneumonia Revenue by Application (2023-2028) & (USD Million)

Table 57. Asia-Pacific Pneumonia Revenue by Region (2017-2022) & (USD Million)

Table 58. Asia-Pacific Pneumonia Revenue by Region (2023-2028) & (USD Million)

Table 59. South America Pneumonia Revenue by Type (2017-2022) & (USD Million)

Table 60. South America Pneumonia Revenue by Type (2023-2028) & (USD Million)

Table 61. South America Pneumonia Revenue by Application (2017-2022) & (USD Million)

Table 62. South America Pneumonia Revenue by Application (2023-2028) & (USD Million)

Table 63. South America Pneumonia Revenue by Country (2017-2022) & (USD Million)

Table 64. South America Pneumonia Revenue by Country (2023-2028) & (USD Million)

Table 65. Middle East & Africa Pneumonia Revenue by Type (2017-2022) & (USD Million)

Table 66. Middle East & Africa Pneumonia Revenue by Type (2023-2028) & (USD Million)

Table 67. Middle East & Africa Pneumonia Revenue by Application (2017-2022) & (USD Million)

Table 68. Middle East & Africa Pneumonia Revenue by Application (2023-2028) & (USD Million)

Table 69. Middle East & Africa Pneumonia Revenue by Country (2017-2022) & (USD Million)

Table 70. Middle East & Africa Pneumonia Revenue by Country (2023-2028) & (USD Million)

List of Figures

Figure 1. Pneumonia Picture

Figure 2. Global Pneumonia Revenue Market Share by Type in 2021

Figure 3. Drugs

Figure 4. Vaccines

Figure 5. Oxygen Therapy

Figure 6. Pneumonia Revenue Market Share by Application in 2021

Figure 7. Hospitals Picture

Figure 8. Ambulatory Surgical Centers Picture

Figure 9. Others Picture

Figure 10. Global Pneumonia Market Size, (USD Million): 2017 VS 2021 VS 2028

Figure 11. Global Pneumonia Revenue and Forecast (2017-2028) & (USD Million)

Figure 12. Global Pneumonia Revenue Market Share by Region (2017-2028)

Figure 13. Global Pneumonia Revenue Market Share by Region in 2021

Figure 14. North America Pneumonia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 15. Europe Pneumonia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 16. Asia-Pacific Pneumonia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 17. South America Pneumonia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 18. Middle East and Africa Pneumonia Revenue (USD Million) and Growth Rate (2017-2028)

Figure 19. Pneumonia Market Drivers

Figure 20. Pneumonia Market Restraints

Figure 21. Pneumonia Market Trends

Figure 22. Pfizer Recent Developments and Future Plans

Figure 23. GlaxoSmithKline(GSK) Recent Developments and Future Plans

Figure 24. Merck Recent Developments and Future Plans

Figure 25. Novartis Recent Developments and Future Plans

Figure 26. Sanofi Recent Developments and Future Plans

Figure 27. Eli Lilly Recent Developments and Future Plans

Figure 28. Global Pneumonia Revenue Share by Players in 2021

Figure 29. Pneumonia Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021

Figure 30. Global Top 3 Players Pneumonia Revenue Market Share in 2021

Figure 31. Global Top 10 Players Pneumonia Revenue Market Share in 2021

Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)

Figure 33. Global Pneumonia Revenue Share by Type in 2021

Figure 34. Global Pneumonia Market Share Forecast by Type (2023-2028)

Figure 35. Global Pneumonia Revenue Share by Application in 2021

Figure 36. Global Pneumonia Market Share Forecast by Application (2023-2028)

Figure 37. North America Pneumonia Sales Market Share by Type (2017-2028)

Figure 38. North America Pneumonia Sales Market Share by Application (2017-2028)

Figure 39. North America Pneumonia Revenue Market Share by Country (2017-2028)

Figure 40. United States Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 41. Canada Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 42. Mexico Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 43. Europe Pneumonia Sales Market Share by Type (2017-2028)

Figure 44. Europe Pneumonia Sales Market Share by Application (2017-2028)

Figure 45. Europe Pneumonia Revenue Market Share by Country (2017-2028)

Figure 46. Germany Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. France Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. United Kingdom Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Russia Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 50. Italy Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 51. Asia-Pacific Pneumonia Sales Market Share by Type (2017-2028)

Figure 52. Asia-Pacific Pneumonia Sales Market Share by Application (2017-2028)

Figure 53. Asia-Pacific Pneumonia Revenue Market Share by Region (2017-2028)

Figure 54. China Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Japan Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. South Korea Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. India Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Southeast Asia Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 59. Australia Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 60. South America Pneumonia Sales Market Share by Type (2017-2028)

Figure 61. South America Pneumonia Sales Market Share by Application (2017-2028)

Figure 62. South America Pneumonia Revenue Market Share by Country (2017-2028)

Figure 63. Brazil Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Argentina Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Middle East and Africa Pneumonia Sales Market Share by Type (2017-2028)

Figure 66. Middle East and Africa Pneumonia Sales Market Share by Application (2017-2028)

Figure 67. Middle East and Africa Pneumonia Revenue Market Share by Country (2017-2028)

Figure 68. Turkey Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 69. Saudi Arabia Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 70. UAE Pneumonia Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 71. Methodology

Figure 72. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz